High prevalence of persistent smell loss and qualitative smell dysfunction during the coronavirus disease 2019 (COVID‐19) pandemic in the United States: Urgent need for clinical trials.

A total of 69.8% (579/829) of responders with smell loss reported that their smell dysfunction had adversely impacted their quality of life (QoL). Keywords: olfaction; olfactory disorders; quality of life EN olfaction olfactory disorders quality of life 1558 1560 3 07/26/23 20230801 NES 230801 The coronavirus disease 2019 (COVID-19) pandemic has put unprecedented strains on healthcare systems across the globe and this is thought to continue with the advent of long COVID. High prevalence of persistent smell loss and qualitative smell dysfunction during the coronavirus disease 2019 (COVID-19) pandemic in the United States: Urgent need for clinical trials. [Extracted from the article]